Dr Emma Wilmot


Importance of TIR as a Complimentary Marker to HbA1C

The Inspirational Bytes are here for you to support the sharing of evidence-based interventions. The aim of these 'Byte Size' meetings is to help reduce the negative effects diabetes can potentially cause to your patients and their families.

Interested? Get in touch with your Sanofi contact person for more details on the session. The meetings are 30 minutes with an optional 30 minute Q&A.

These promotional meetings are organised and funded by Sanofi.

Get In Touch

About Emma Wilmot

emma wilmot

Emma Wilmot is a Consultant Diabetologist with specialist interests which include Type 1 diabetes, insulin pump therapy and diabetes technology, young adults with diabetes and antenatal diabetes care.

She was awarded the University of Leicester medal for excellent PhD performance in 2013 for her PhD “Type 2 diabetes in younger adults” and was appointed as an Honorary (consultant) Assistant Professor at the University of Nottingham in 2018. She is a principal investigator on diabetes research trials.

She is the founder of the ABCD Diabetes Technology Network UK. As chair she previously led the delivery of educational events for multidisciplinary diabetes teams and the development of a suite of national diabetes technology ‘best practice’ guides, in addition to online modules for people living with diabetes. Emma is an elected Association of British Clinical Diabetologists (ABCD) committee member and DAFNE structured education executive board member. She is a member of the National Diabetes Audit Insulin Pump Expert Reference Group and has also been involved in the #languagematters movement. 

Interested in running or joining this session?

Reach out to your Sanofi contact person. Together you can discuss next steps.

 

Get In Touch

 

lady speaking on phone
Always up to date?

Webinars, evidence, expert videos, peer-to-peer events... Do you want to be the first to know when new, relevant information is available? Let us know and we'll send you a message.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to the Sanofi drug safety department on 0800 0902 314. Alternatively, send via email to UK-drugsafety@sanofi.com. Prescribing information will be available at the meeting.
This site uses cookies to store information on your computer. Some cookies on this site are needed because the site won’t work as expected without them. To learn more about cookies, please read our Cookie Policy.
By closing this message or using the website, you agree to our use of cookies on this device in agreement with our Cookie Policy, unless you have turned them off.
Accept and close